» Authors » Dietmar Boethig

Dietmar Boethig

Explore the profile of Dietmar Boethig including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 113
Citations 1104
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Poyanmehr R, Hanke J, Boethig D, Merzah A, Karsten J, Frank P, et al.
Circ Heart Fail . 2025 Jan; 18(2):e012154. PMID: 39831321
Background: Consensus regarding on-support evaluation and weaning concepts from Impella 5.5 support is scarce. The derived left ventricular end-diastolic pressure (dLVEDP), estimated by device algorithms, is a rarely reported tool...
2.
Salman J, Franz M, Aburahma K, De Manna N, Tavil S, Ali-Hasan-Al-Saegh S, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064309
: Minimally invasive mitral valve surgery (MIMVS) is a treatment for severe mitral valve pathologies. In redo cases, especially after coronary artery bypass grafting (CABG) surgery with patent mammary bypass...
3.
Franz M, Aburahma K, Ius F, Ali-Hasan-Al-Saegh S, Boethig D, Hertel N, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064222
: Mitral valve infective endocarditis (IE) still has a high mortality. Minimally invasive mitral valve surgery (MIMVS) is technically more challenging, especially in patients with endocarditis. Here, we compare the...
4.
5.
Horke A, Tudorache I, Laufer G, Andreas M, Pomar J, Pereda D, et al.
Eur J Cardiothorac Surg . 2024 Mar; 65(4). PMID: 38532304
Objectives: Decellularized aortic homografts (DAH) were introduced as a new option for aortic valve replacement for young patients. Methods: A prospective, EU-funded, single-arm, multicentre study in 8 centres evaluating non-cryopreserved...
6.
Horke A, Bobylev D, Avsar M, Cvitkovic T, Meyns B, Rega F, et al.
Eur J Cardiothorac Surg . 2024 Mar; 65(4). PMID: 38532286
Objectives: Decellularized aortic homografts (DAH) were introduced in 2008 as a further option for paediatric aortic valve replacement (AVR). Methods: Prospective, multicentre follow-up of all paediatric patients receiving DAH for...
7.
Franz M, Tavil S, De Manna N, Aburahma K, Boethig D, Bobylev D, et al.
J Heart Lung Transplant . 2024 Mar; 43(7):1126-1134. PMID: 38438087
Background: Lung transplantation is the only curative treatment for patients with end-stage pulmonary fibrosis. It is still under debate whether over- or undersizing of lung allografts is preferably performed regarding...
8.
Vetter L, Sumpelmann R, Rudolph D, Roher K, Vetter M, Boethig D, et al.
Paediatr Anaesth . 2024 Jan; 34(5):454-458. PMID: 38269449
Background: The German guidelines recommend that intravenous fluid therapy should not be mandatorily performed in children with short fasting times undergoing short anesthesia, but there is a lack of clinical...
9.
Heise E, Chichelnitskiy E, Greer M, Franz M, Aburahma K, Iablonskii P, et al.
Am J Transplant . 2023 May; 23(11):1740-1756. PMID: 37225088
Pretransplant allosensitization to human leukocyte antigens (HLA) increases the recipient's waiting list time and mortality in lung transplantation. Rather than waiting for crossmatch-negative donors, since 2013, recipients with preformed donor-specific...
10.
Aburahma K, de Manna N, Boethig D, Franz M, Iablonskii P, Heise E, et al.
Eur J Cardiothorac Surg . 2023 May; 63(6). PMID: 37171893
Objectives: Total ischaemic time (IT) is considered a limiting factor in lung transplantation. In this retrospective study, we investigate effects of IT and disease burden on outcomes after bilateral lung...